Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Sofinnova Partners

Tracked across 5 events · 49 articles · First seen Jul 05, 2026 · Last active Sep 18, 2026

Sentiment
28
Attention
6
Events
5
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 50
Business
Impact: Sofinnova Partners, an existing investor, participated in the round, affirming its belief in Mironid's potential.
Aug 05, 2026 · 7 articles
2 10
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Participated in the oversubscribed private placement financing.
Sep 17, 2026 · 6 articles
4 50
Business
Impact: As an existing investor in Pi-Cardia Ltd., Sofinnova Partners stands to benefit from the increased valuation and potential acquisition.
Sep 01, 2026 · 9 articles
6 30
Business
Impact: Sofinnova Partners provided seed investment to Myricx Bio, supporting its initial stages of development.
Jul 05, 2026 · 21 articles
2 0
Business
Impact: Investor in Mission.
Jul 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sofinnova Partners live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.